USA - NASDAQ:ATPC - US0083892077 - Common Stock
The current stock price of ATPC is 1.3 USD. In the past month the price increased by 8.33%. In the past year, price decreased by -10.72%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.51 | 106.05B | ||
| COR | CENCORA INC | 22.65 | 70.21B | ||
| CAH | CARDINAL HEALTH INC | 23.33 | 49.40B | ||
| HSIC | HENRY SCHEIN INC | 14.87 | 8.69B | ||
| AHCO | ADAPTHEALTH CORP | 28.66 | 1.24B | ||
| OMI | OWENS & MINOR INC | 2.17 | 216.66M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 48.72M |
Agape ATP Corp. engages in the provision of health and wellness products and advisory services in the Malaysian market. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan and currently employs 16 full-time employees. The company went IPO on 2018-09-17. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The firm offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
AGAPE ATP CORP
1705-1708 Level 17, Tower 2, Faber Tower, Jalan Desa Bahagia, Taman Desa
KUALA LUMPUR WILAYAH PERSEKUTUAN MY
Employees: 16
Phone: 60327325716
Agape ATP Corp. engages in the provision of health and wellness products and advisory services in the Malaysian market. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan and currently employs 16 full-time employees. The company went IPO on 2018-09-17. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The firm offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
The current stock price of ATPC is 1.3 USD. The price increased by 2.36% in the last trading session.
ATPC does not pay a dividend.
ATPC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
AGAPE ATP CORP (ATPC) will report earnings on 2026-03-30.
You can find the ownership structure of AGAPE ATP CORP (ATPC) on the Ownership tab.
ChartMill assigns a technical rating of 3 / 10 to ATPC. When comparing the yearly performance of all stocks, ATPC is a bad performer in the overall market: 65.98% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ATPC. ATPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ATPC reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 56.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.12% | ||
| ROE | -11.87% | ||
| Debt/Equity | 0 |